FURUHATA Kunikazu | Research Laboratories, Toyama Chemical Co., Ltd.
スポンサーリンク
概要
関連著者
-
古畑 公夫
北里大薬
-
Narita H
Toyama Chemical Co. Ltd. Toyama Jpn
-
NARITA Hirokazu
Research Institute for Environmental Management Technology National Institute of Advanced Industrial
-
WATANABE Yasuo
Research Laboratories, Toyama Chemical Co., Ltd.
-
Watanabe Yoshiko
Department Of Pharmacology Kobe Pharmaceutical University
-
Narita H
Discovery Research Laboratory Tanabe Seiyaku Co. Ltd
-
FURUHATA Kunikazu
Research Laboratories, Toyama Chemical Co., Ltd.
-
Furuhata K
Research Laboratories Toyama Chemical Co. Ltd.
-
Watanabe Yasuo
Research Laboratories Of Toyama Chemical Co Ltd
-
WATANABE Yasuo
Research and Development Division, Oriental Yeast Co., Ltd.
-
SOUMI Keiji
Research Laboratories, Toyama Chemical Co., Ltd.,
-
ARAI Hirotoshi
Research Laboratories, Toyama Chemical Co., Ltd.,
-
Soumi Keiji
Clinical Research Department Toyama Chemical Co. Ltd.
-
Arai Hirotoshi
Research Laboratories, Toyama Chemical Co., Ltd.
-
HAYAKAWA Hiroyoshi
Research Laboratories, Toyama Chemical Co. Ltd
-
TODO Yozo
Research Laboratories, Toyama Chemical Co., Ltd.
-
TAKAKURA Tadakazu
Research Laboratories, Toyama Chemical Co., Ltd.
-
FUKUDA Yoshiko
Research Laboratories, Toyama Chemical Co., Ltd.,
-
Fukuda Yoshiko
Research Laboratories Toyama Chemical Co. Ltd.
-
Todo Yozo
Research Laboratories Toyama Chemical Co. Ltd.
-
Takakura Tadakazu
Research Laboratories Toyama Chemical Co. Ltd.
-
Hayakawa H
Research Laboratories Toyama Chemical Co. Ltd.
-
Hayakawa Hiroyoshi
Research Laboratories Toyama Chemical Co. Ltd
著作論文
- Pharmacological Properties of T-3762,a Novel Fluoroquinolone Antimicrobial Agent in Parenteral Use. III. Chemical Structures and Dermovascular Permeability-Increasing Activities
- Histamine-Releasing Properties of T-3762,a Novel Fluoroquinolone Antimicrobial Agent in Intravenous Use. II. Dermovascular Permeability-Increasing Effect and Action on Peritoneal Mast Cells
- Histamine-Releasing Properties of T-3762,a Novel Fluoroquinolone Antimicrobial Agent in Intravenous Use. I. Effects of Doses and infusion Rate on Blood Pressure, Heart Rate and Plasma Histamine Concentration